From: Efficacy and safety of FDG-PET for determining target volume during intensity-modulated radiotherapy for head and neck cancer involving the oral level
Acute adverse events
Grade 2 (%)
Grade 3 (%)
Grade 4 (%)
Dermatitis
33
22
0
Mucositis
66
Dysphagia
Dry mouth
44
Taste disorder